News
Introducing our new ESDR Board members 2026
We are delighted to welcome our new ESDR Board members. Your expertise, fresh perspectives, and...
ESDR2026 Abstract and eprogram books are available
Access the ESDR2026 Abstract and e-program books here [button...
Early Bird Registration ends on 8 July 11.59pm CEST!
https://esdrmeeting.org/registration/ Don't miss your chance to save up to €195 on your...
2026 ISID-LEO Foundation Awards EMEA Region
ISID and LEO Foundation Partner to Expand Global Reach of Early-Career Awards Inaugural...
An exceptional result!
Thank you to our incredible research community for this outstanding response. Whether you...
ESDR2026 confirmed keynotes speakers
Dear Colleagues, dear Friends, We are delighted to announce that our keynote speakers and...
About The ESDR
The European Society for Dermatological Research (ESDR), founded in 1970, is a non-profit organization promoting basic and clinical science related to dermatology. The ESDR is the largest investigative dermatology society in Europe with a current membership of over 1200.
By supporting investigative dermatology, the ESDR contributes towards improving the health of patients suffering from skin and venereal disease. Applications of recent scientific advances have produced diagnostic and therapeutic innovations in dermatological practice, particularly in genetics, skin cancer, allergic skin disease, infectious disease and autoimmune diseases.
ABOUT JID
The Journal of Investigative Dermatology (JID) is the official journal of the ESDR and SID. JID publishes papers describing original research on all aspects of cutaneous biology and skin disease. Topics include biochemistry, biophysics, cell regulation, carcinogenesis, skin structure, extracellular matrix, genetics, immunology, melanocyte biology, microbiology, molecular and cell biology, pathology, physiology, pharmacology, photobiology, percutaneous absorption, clinical research, epidemiology and other population-based research.
JID Latest
- The itch-dominant phenotype of atopic dermatitis carries a disproportionate psychosocial burden
- DNPH1 exerts context-dependent tumor-promoting and -repressing functions during melanoma development
- Accumulation of the immunosuppressive metabolite 1-methylnicotinamide in human basal cell carcinoma
- The left middle frontal gyrus: A potential central hub for rosacea in the brain–skin axis
- Proteomic signature predicts the metastatic risk of primary cutaneous squamous cell carcinomas
